(TSX-V:RKV), VANCOUVER, British Columbia, Jan. 22, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company at the forefront of AI-driven drug discovery, yesterday commented on the announcement of a $500 billion private-sector investment into AI infrastructure by OpenAI, SoftBank, and Oracle through their joint venture, Stargate. This historic initiative marks a defining […]

(NasdaqGM:FCEL), DANBURY, Conn., Jan. 22, 2025 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL), a Connecticut-based global leader in delivering clean, innovative fuel cell solutions for the supply, recovery, and storage of energy, announced that it will build a 7.4 MW fuel cell power plant in Hartford, Conn. The project will deliver Class 1 renewable

(NASDAQ:ELTX), Received supportive FDA feedback on key elements of the potential ELI-002 Phase 3 study design, including dose, schedule, patient population and primary endpoint analysis Phase 2 randomized study of ELI-002 fully enrolled, with formal interim analysis of disease-free survival (“DFS”) expected in H1 2025; positive results could support rapid advancement into Phase 3 development

(NASDAQ:STRM), ATLANTA, Jan. 22, 2025 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of RevID with a 120-bed, Oracle Health-EHR based health system with facilities in Kentucky. Closed in partnership

(NYSE:UCB),(NYSE:UCB-PI), GREENVILLE, S.C., Jan. 22, 2025 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NYSE: UCB) (United) today announced net income for the fourth quarter of 2024 of $75.8 million and pre-tax, pre-provision income of $108 million. Diluted earnings per share of $0.61 for the quarter represented an increase of $0.50 from the fourth quarter a

(NasdaqGM:NTLA), CAMBRIDGE, Mass., Jan. 22, 2025 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced the first patient has been dosed in the global Phase 3 study of NTLA-2002 for the treatment of hereditary angioedema (HAE). NTLA-2002 is a wholly owned investigational

(NYSE:COHR), PITTSBURGH, Jan. 22, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in laser and photonic solutions, today announces the launch of new pin-hole array biochips for medical diagnostics, with a focus on gene sequencing applications. Developed by the Coherent advanced optics team, this groundbreaking approach consolidates the entire production process, addressing

(CNSX:HG.CN),(OTC US:HGRAF),(Other OTC:HGRAF),(Frankfurt:M98), TORONTO, Jan. 22, 2025 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (FRA: M98) (the “Company” or “HydroGraph”), a sustainable commercial manufacturer of pristine graphene, has announced its second research study in partnership with Arizona State University (ASU) highlighting the advancements in extending the use of HydroGraph's Fractal Graphene(TM)

(NASDAQ:REKR), COLUMBIA, Md., Jan. 22, 2025 (GLOBE NEWSWIRE) — Rekor Systems, Inc. (NASDAQ: REKR), a leader in developing and implementing state-of-the-art roadway intelligence technology, has achieved New Jersey's rigorous certification for its industry-leading Rekor Scout(R) vehicle recognition platform. This milestone secures Rekor's strong position in the New Jersey Statewide Networked ALPR Program (NJ SNAP), a

(NASDAQ:SYBT), LOUISVILLE, Ky., Jan. 22, 2025 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today reported record earnings of $31.7 million, or $1.07 per diluted